Provided by Tiger Trade Technology Pte. Ltd.

Acurx Pharmaceuticals, LLC*

6.63
+1.4227.26%
Post-market: 6.790.1600+2.41%19:59 EDT
Volume:7.80M
Turnover:52.02M
Market Cap:18.93M
PE:-1.25
High:7.54
Open:5.01
Low:5.01
Close:5.21
52wk High:21.00
52wk Low:1.33
Shares:2.86M
Float Shares:2.42M
Volume Ratio:1.38
T/O Rate:322.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.3200
EPS(LYR):-17.4507
ROE:-270.80%
ROA:-87.59%
PB:3.59
PE(LYR):-0.38

Loading ...

Mar 12, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2026

Major Issues Report

Form 8-K - Current report
Feb 02, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 21, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 22, 2025

Major Issues Report

Form 8-K - Current report
Sep 19, 2025

Major Issues Report

Form 8-K - Current report
Aug 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2025

Major Issues Report

Form 8-K - Current report
Jul 22, 2025

Correspondence

Form CORRESP - Correspondence
Jul 17, 2025

Major Issues Report

Form 8-K - Current report
Jul 15, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 20, 2025

Major Issues Report

Form 8-K - Current report
May 28, 2025

Correspondence

Form CORRESP - Correspondence
May 21, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

Major Issues Report

Form 8-K - Current report
Apr 11, 2025

Correspondence

Form CORRESP - Correspondence